<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1242</ReferenceId>
        <DateLastUpdated>2020-10-11-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14551186</PubmedId>
            <Abstract>CD1 proteins are antigen-presenting molecules that bind foreign and self-lipids and stimulate specific T cell responses. In the current study, we investigated ligand binding by CD1 proteins by developing a fluorescent probe binding approach using soluble recombinant human CD1 proteins. To increase stability and yield, soluble group 1 CD1 (CD1b and CD1c) and group 2 CD1 (CD1d) proteins were produced as single chain secreted CD1 proteins in which beta2-microglobulin was fused to the N termini of the CD1 heavy chains by a flexible peptide linker sequence. Analysis of ligand binding properties of single chain secreted CD1 proteins by using fluorescent lipid probes indicated significant differences in ligand preference and in pH dependence of binding by group 1 versus group 2 CD1 proteins. Whereas group 1 CD1 isoforms (CD1b and CD1c) show stronger binding of nitrobenzoxadiazole (NBD)-labeled dialkyl-based ligands (phosphatidylcholine, sphingomyelin, and ceramide), group 2 CD1 (CD1d) proteins were stronger binders of small hydrophobic probes such as 1-anilinonaphthalene-8-sulfonic acid and 4,4'-dianilino-1,1'-naphthyl-5,5'-disulfonic acid. Competition studies indicated that binding of fluorescent lipid probes involved association of the probe with the hydrophobic ligand binding groove of CD1 proteins. Analysis of selected alanine substitution mutants of human CD1b known to inhibit antigen presentation showed that NBD-labeled lipid probe binding could be used to distinguish mutations that interfere with ligand binding from those that affect T cell receptor docking. Our findings provide further evidence for the functional specialization of different CD1 isoforms and demonstrate the value of the fluorescent lipid probe binding method for assisting structure-based studies of CD1 function.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>299-310</ArticlePages>
            <ArticleTitle>Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Im</LastName>
                    <ForeName>Jin S</ForeName>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Karl O A</ForeName>
                </Author>
                <Author>
                    <LastName>Illarionov</LastName>
                    <ForeName>Petr A</ForeName>
                </Author>
                <Author>
                    <LastName>LeClair</LastName>
                    <ForeName>Kenneth P</ForeName>
                </Author>
                <Author>
                    <LastName>Storey</LastName>
                    <ForeName>James R</ForeName>
                </Author>
                <Author>
                    <LastName>Kennedy</LastName>
                    <ForeName>Malcolm W</ForeName>
                </Author>
                <Author>
                    <LastName>Besra</LastName>
                    <ForeName>Gurdyal S</ForeName>
                </Author>
                <Author>
                    <LastName>Porcelli</LastName>
                    <ForeName>Steven A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antigens;Antigens, CD1;Antigens, CD1d;CD1C protein, human;CD1D protein, human;CD1b antigen;Epitopes;Fluorescent Dyes;Glycoproteins;Hemagglutinin Glycoproteins, Influenza Virus;Recombinant Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Monoclonal(chemistry); Antigens(chemistry); Antigens, CD1(chemistry); Antigens, CD1d; Binding Sites; Binding, Competitive; CHO Cells; Cell Line; Cricetinae; Epitopes(chemistry); Fluorescent Dyes; Glycoproteins(chemistry); Hela Cells; Hemagglutinin Glycoproteins, Influenza Virus(chemistry); Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation; Recombinant Proteins(chemistry); Transfection</ArticleMeshHeadingsList>
            <Journal>
                <Volume>279</Volume>
                <Issue>1</Issue>
                <Title>The Journal of biological chemistry</Title>
                <Issn>1083-351X</Issn>
                <MedlineTa>J Biol Chem</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>GMM</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Glycolipid</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59474</ChEBIId>
                        </Molecule>
                        <SourceOrganismId>1763</SourceOrganismId>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Authors communication</LocationOfData>
                <EpitopeId>131176</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope name stands for glucose 6-monomycolate, glycolipid antigen of mycobacterium, known to be presented by CD1b molecules.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4B</LocationOfData>
                        <TCellId>18096</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1763</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <SecondInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1769</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M. leprae extract</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </SecondInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD8-/CD4-</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1769</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell line LDN5 from where TCR chains were derived was previously detailed in Moody et al, Science. 1997 278(5336):283 [PMID: 9323206]. It is a CD4-CD8- TCRalphabeta+ T cell line isolated from a skin biopsy of a cutaneous reaction to Mycobacterium leprae antigen and stimulated with autologous GM-CSF– and IL-4–treated CD1+ monocytes and M. leprae sonicate. After establishment of the cell line, it was periodically stimulated with allogenic CD1+ APCs and M. phlei sonicate. The TCR chains were used to transfect a TCR- Jurkart cell line to obtain LDN5/JRT3.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>LDN5</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Kidney</CellTissueType>
                            <CellType>293-T-Epithelial cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>154</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>GMM</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Glycolipid</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59474</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>1763</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific-TCR-transfectant Jurkat cells produce IL-2 upon incubation with human CD1b transfected 293T cells and epitope, showing that the CD1b molecules are functional. Better results are obtained with a single chain construct, where beta2-microglobulin is covalently attached to the N-ter of CD1b by a 15-mer linker than with the native (non-covalently linked heterodimer) molecule.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Mannosyl phosphoisoprenoid</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Glycolipid</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59631</ChEBIId>
                        </Molecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Authors communication</LocationOfData>
                <EpitopeId>134622</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Mycobacterium glycolipid recently reclassified as mannosyl-β-1-phosphomycoketides, known to be presented by CD1c molecules. The chemical formula (for M. tuberculosis) is C&lt;sub&gt;38&lt;/sub&gt;H&lt;sub&gt;76&lt;/sub&gt;O&lt;sub&gt;9&lt;/sub&gt;P. It is naturally found in the lipid extracts from M. tuberculosis.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4C</LocationOfData>
                        <TCellId>18755</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenReferenceName>M. tuberculosis extract</ImmunogenReferenceName>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>T cell line CD8-1 from where TCR chains were derived was previously detailed in Stenger et al, Science. 1997 276(5319):1684 [PMID:9180075]. Briefly, CD8 T cells from either healthy or infected donors (no specification for this line is provided) were subjected to immunomagnetic depletion and culture with M. tuberculosis extract (supernatant of ultracentrifuged probe-sonicate of the virulent M. tuberculosis strain H37Rv) in the presence of peripheral blood mononuclear cells (PBMCs) treated with GMCSF and interleukin-4 to induce CD1 expression and maintained by biweekly stimulation with M. tuberculosis extract in the presence of heterologous CD1+ APCs.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>CD8-1</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Kidney</CellTissueType>
                            <CellType>HeLa cells-Epithelial cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>155</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M. tuberculosis lipid extract</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific-TCR-transfectant Jurkat cells produce IL-2 upon incubation with human CD1c transfected HeLa cells and M.tuberculosis lipid extract (containing the epitope), showing that the CD1c molecules are functional. Similar, albeit better, results are obtained with a single chain construct, where beta2-microglobulin is covalently attached to the N-ter of CD1b by a 15-mer linker than with the native (non-covalently linked heterodimer) molecule.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>α-Galactosylceramide</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Other Non-Sequence</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59446</ChEBIId>
                        </Molecule>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Authors communication</LocationOfData>
                <EpitopeId>131185</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Synthetic glycolipid, known to be presented by CD1d molecules. The structure is (2S,3S,4R)-1-O-(a-D-galactopyranosyl)-N-tetracosanoyl-2-amino-1,3,4-octadecanetriol.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 4E, 4D, 6B</LocationOfData>
                        <TCellId>18760</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>9 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>NK T cell hybridoma (a-GalCer specific) was previously described. It is derived from mature CD5hiCD44hiCD4-CD8- (DN) thymocytes from a normal mouse, as described in Lantz and Bendelac, J Exp Med. 1994 180(3):1097 [PMID: 7520467].</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Thymus</CellTissueType>
                            <CellType>NKT cells</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>DN32.D3</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>156</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>α-Galactosylceramide</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59446</ChEBIId>
                                        </Molecule>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>77</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific NK-T cell hybridoma cells produce IL-2 upon incubation with soluble, single-chain, human CD1d (where B2-microglobulin is linked to the N-ter of CD1 by a 15-mer linker) and epitope, showing that the CD1 molecules are functional. Similar results are also seen with native or single-chain CD1d-transfected HeLa cells, confirming that both in the soluble and membrane-bound forms, CD1 molecules are able to present epitope. The induction of the epitope specific NK T cell  hybridoma is shown to be inhibited by previous incubation of CD1 molecules with fluorescent phospholipids probes, which were subsequently used to assay the binding properties of the different isoforms of CD1 molecules.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NBD-C6-Cer</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Other Non-Sequence</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59423</ChEBIId>
                        </Molecule>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6</LocationOfData>
                <EpitopeId>131180</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Synthetic sphingolipid fluorescent probe related to known CD1 ligands, not shown to serve as T cell target.  Epitope name stands for 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosine.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20970</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>300.0</QuantitativeMeasurement>
                            <AssayComments>At pH 4, there is a 300% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules. Increase in fluorescence is about 200% at pH 7. The analysis of binding to mutant CD1b molecules show that the mutation of Y169 to alanine abolishes binding of epitope by ~50%, while mutation of D83 residue to alanine doesn’t affect binding (Figure 7c).  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>154</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20973</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>150.0</QuantitativeMeasurement>
                            <AssayComments>Binding signal above background (in the absence of protein) is very weak, but slightly enhanced at pH 4 compared to pH 7. This is confirmed by the lack of inhibition by this molecule of the binding to the natural ligand for this molecule, αGalCer (Figure 6B).  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>156</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20972</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>300.0</QuantitativeMeasurement>
                            <AssayComments>At pH 4, there is a 300% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules, while a slightly lower increase is seen at pH 7.  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>155</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NBD-C6-SM</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Other Non-Sequence</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59429</ChEBIId>
                        </Molecule>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6</LocationOfData>
                <EpitopeId>131179</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Synthetic sphingolipid fluorescent probe (where the polar head consists of phosphocholine) related to known CD1 ligands, not shown to serve as T cell target.  Epitope name stands for 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino)hexanoyl)sphingosyl phosphocholine.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 6B</LocationOfData>
                        <TCellId>22171</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>9 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>NK T cell hybridoma (a-GalCer specific) was previously described. It is derived from mature CD5hiCD44hiCD4-CD8- (DN) thymocytes from a normal mouse, as described in Lantz and Bendelac, J Exp Med. 1994 180(3):1097 [PMID: 7520467].</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Thymus</CellTissueType>
                            <CellType>NKT cells</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>DN32.D3</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>156</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NBD-C6-SM</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59429</ChEBIId>
                                        </Molecule>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>77</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Even when the fluorescence of this molecule is not enhanced upon incubation with CD1d molecules, inhibition of binding of the natural ligand (α-GalCer) for this MHC molecule could be demonstrated. This is seen as a decrease in the responsiveness of a αGalCer-specific NK-T hybridoma upon incubation with plate-bound CD1d molecules loaded with ligand after preincubation with the fluorescent probe.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20975</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>200.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                            <AssayComments>At pH 4, there is a 150-200% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules. Increase in fluorescence is very weak at pH 7.The analysis of binding to mutant CD1b molecules show that the mutation of Y169 to alanine abolishes binding of epitope by ~50%, while mutation of D83 residue to alanine doesn’t affect binding (Figure 7c).  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>154</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20976</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Binding signal is not above background.  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>156</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20974</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>200.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                            <AssayComments>At pH 4, there is a 150-200% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules, while at pH 7 the effect is weaker.  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>155</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NBD-C6-HPC</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Other Non-Sequence</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59426</ChEBIId>
                        </Molecule>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6</LocationOfData>
                <EpitopeId>131181</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Synthetic diacylglicerol-phosphocholine fluorescent probe related to known CD1 ligands, not shown to serve as T cell target.  Epitope name stands for 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)hexanoyl-1-hexadecanoyl-sn-glycero-3-phosphocholine.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 6B</LocationOfData>
                        <TCellId>22177</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Age>9 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>NK T cell hybridoma (a-GalCer specific) was previously described. It is derived from mature CD5hiCD44hiCD4-CD8- (DN) thymocytes from a normal mouse, as described in Lantz and Bendelac, J Exp Med. 1994 180(3):1097 [PMID: 7520467].</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Thymus</CellTissueType>
                            <CellType>NKT cells</CellType>
                            <CellCultureConditions>Cell Line / Clone (Hybridoma)</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>DN32.D3</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <MhcAllele>
                            <MhcAlleleId>156</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NBD-C6-HPC</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Other Non-Sequence</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59426</ChEBIId>
                                        </Molecule>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>77</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Even when the fluorescence of this molecule is weakly enhaced upon incubation with CD1d molecules, inhibition of binding of the natural ligand (α-GalCer) for this MHC molecule could be demonstrated. This is seen as a decrease in the responsiveness of a αGalCer-specific NK-T hybridoma upon incubation with plate-bound CD1d molecules loaded with ligand after preincubation with the fluorescent probe.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20979</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Binding signal is slighly above background.  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>156</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20977</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>500.0</QuantitativeMeasurement>
                            <AssayComments>At pH 4, there is a ~500% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules, while at pH 7 this increase is of ~350%.  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>155</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20978</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>500.0</QuantitativeMeasurement>
                            <AssayComments>At pH 4, there is a 500% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules.At pH 7, that increase is of ~200%. The analysis of binding to mutant CD1b molecules show that the mutation of Y169 to alanine abolishes binding of epitope by ~50%, while mutation of D83 residue to alanine doesn’t affect binding (Figure 7c).  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>154</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NBD-C12-HPC</EpitopeName>
                <EpitopeStructure>
                    <AccessionNonSequenceMolecule>
                        <ChemicalType>Other Non-Sequence</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59416</ChEBIId>
                        </Molecule>
                    </AccessionNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6</LocationOfData>
                <EpitopeId>131178</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Synthetic diacylglicerol-phosphocholine fluorescent probe related to known CD1 ligands, not shown to serve as T cell target.  Epitope name stands for 2-(12-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl-1-hexadecanoyl-sn-glycero-3-phosphocholine.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20983</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>500.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>At pH 4, there is a &gt;500% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules.At pH 7, that increase is of ~200%.  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>155</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20984</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>300.0</QuantitativeMeasurement>
                            <AssayComments>At pH 4, there is a 300% increase in fluorescence at λ&lt;sub&gt;max&lt;/sub&gt; upon incubation with CD1 molecules. At pH 7, that increase is of ~150%. The analysis of binding to mutant CD1b molecules show that the mutation of Y169 to alanine abolishes binding of epitope by &gt;50%, while mutation of D83 residue to alanine doesn’t affect binding  (Figure 7c).  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>154</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig 6c</LocationOfData>
                        <MhcBindingId>20985</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>278</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Binding signal at pH 7 is weak, and not greatly enhanced at pH 4. This is confirmed by the lack of inhibition by this molecule of the binding to the natural ligand for this molecule, αGalCer (Figure 6B)  1 μM probe and 0.5 μM CD1 protein were incubated for binding fluorescence measurement, both at pH 7 and 4.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>156</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

